- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
189
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
189 companies
Genor Biopharma Holdings
Market Cap: HK$2.0b
A biopharmaceutical company, focuses on developing and commercializing oncology and autoimmune drugs in China and internationally.
6998
HK$3.94
7D
-5.5%
1Y
n/a
Sona Nanotech
Market Cap: CA$68.9m
Operates as a nanotechnology life sciences company.
SONA
CA$0.60
7D
1.7%
1Y
114.3%
Elite Pharmaceuticals
Market Cap: US$686.8m
A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.
ELTP
US$0.64
7D
-1.8%
1Y
63.7%
Tiziana Life Sciences
Market Cap: US$196.2m
A biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States.
TLSA
US$1.97
7D
18.7%
1Y
109.6%
Inhibitor Therapeutics
Market Cap: US$8.6m
A pharmaceutical development company, develops and commercializes therapeutics for patients with certain cancers and non-cancerous proliferation disorders in the United States.
INTI
US$0.05
7D
16.0%
1Y
-37.6%
Malaysian Genomics Resource Centre Berhad
Market Cap: RM 26.1m
Provides genetics, genomics, immunotherapy, and biopharmaceutical services worldwide.
MGRC
RM 0.20
7D
5.3%
1Y
-43.7%
Frontage Holdings
Market Cap: HK$2.6b
A contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies.
1521
HK$1.25
7D
-8.8%
1Y
71.2%
Savara
Market Cap: US$733.2m
A clinical stage biopharmaceutical company, focuses on rare respiratory diseases.
SVRA
US$3.51
7D
-2.5%
1Y
-15.4%
Rapid Micro Biosystems
Market Cap: US$143.7m
A life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally.
RPID
US$3.16
7D
3.6%
1Y
272.9%
Race Oncology
Market Cap: AU$587.5m
A clinical stage biopharmaceutical company, focuses on addressing the unmet needs of cancer patients for damaging treatments.
RAC
AU$3.11
7D
21.0%
1Y
71.3%
Gulf Pharmaceutical Industries P.S.C
Market Cap: د.إ1.5b
Manufactures and sells medicines, drugs, and various other types of pharmaceutical, cosmetic, and medical compounds in United Arab Emirates, other GCC countries, and internationally.
JULPHAR
د.إ1.29
7D
-2.3%
1Y
44.6%
Biosino Bio-Technology and Science Incorporation
Market Cap: HK$125.9m
Manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China.
8247
HK$0.87
7D
-10.3%
1Y
27.9%
Kanabo Group
Market Cap: UK£1.4m
A digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices.
KNB
UK£0.0022
7D
0%
1Y
-82.0%
Shattuck Labs
Market Cap: US$114.5m
A biotechnology company, develops antibodies for the treatment of inflammatory and immune-mediated diseases.
STTK
US$2.35
7D
21.1%
1Y
-35.3%
Genenta Science
Market Cap: US$53.8m
A clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy.
GNTA
US$3.15
7D
1.6%
1Y
-21.3%
Cilo Cybin Holdings
Market Cap: R211.6m
Cilo Cybin Holdings Limited cultivates, manufactures, and sells medical cannabis products worldwide.
CCC
R2.98
7D
1.0%
1Y
-25.5%
AIM Vaccine
Market Cap: HK$5.1b
Engages in the research and development, manufacture, and sale of vaccine products for human use in the People’s Republic of China.
6660
HK$4.14
7D
-7.2%
1Y
-7.0%
Tissue Repair
Market Cap: AU$17.5m
A clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia.
TRP
AU$0.28
7D
0%
1Y
-23.6%
Enzon Pharmaceuticals
Market Cap: US$5.9m
Does not have significant operations.
ENZN
US$0.08
7D
6.7%
1Y
-34.3%
Harvard Apparatus Regenerative Technology
Market Cap: US$34.2m
A clinical-stage biotechnology company, focuses on developing regenerative-medicine treatments for disorders of the gastro-intestinal system and other organs resulting from cancer, trauma, or birth defects.
HRGN
US$1.99
7D
6.4%
1Y
-64.0%
Hexima
Market Cap: AU$2.2m
Does not have significant operations.
HXL
AU$0.013
7D
0%
1Y
-18.8%
Autolus Therapeutics
Market Cap: US$359.3m
A clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in United Kingdom and internationally.
AUTL
US$1.56
7D
22.8%
1Y
-54.8%
Spero Therapeutics
Market Cap: US$113.1m
A clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States.
SPRO
US$1.97
7D
3.7%
1Y
53.9%
Anixa Biosciences
Market Cap: US$112.6m
A biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology.
ANIX
US$3.44
7D
2.7%
1Y
9.2%
Arecor Therapeutics
Market Cap: UK£27.4m
A clinical stage biotechnology company, develops innovative medicines that address significant unmet patient needs in the United Kingdom.
AREC
UK£0.72
7D
0.7%
1Y
7.4%
CytoMed Therapeutics
Market Cap: US$23.7m
A pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore.
GDTC
US$2.03
7D
8.0%
1Y
38.1%
Vivoryon Therapeutics
Market Cap: €42.8m
Operates as a clinical stage biopharmaceutical company that focuses on research, development, and commercialize small molecule-based medicines.
VVY
€1.63
7D
-0.6%
1Y
-28.7%
BCAL Diagnostics
Market Cap: AU$24.9m
A screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer.
BDX
AU$0.07
7D
1.4%
1Y
-44.0%
Neurizon Therapeutics
Market Cap: AU$68.9m
A clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases.
NUZ
AU$0.13
7D
-10.3%
1Y
-35.0%
Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd
Market Cap: HK$8.3b
Engages in the research, development, manufacture, and sale of bio-pharmaceutical products in the People's Republic of China.
1349
HK$3.54
7D
-7.3%
1Y
80.6%
LIDDS
Market Cap: SEK 9.5m
A drug delivery company, develops pharmaceutical products based on its NanoZolid proprietary technology for the treatment of cancer and other diseases in Sweden.
LIDDS
SEK 0.07
7D
-2.5%
1Y
-40.0%
Starpharma Holdings
Market Cap: AU$92.0m
A biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications internationally.
SPL
AU$0.23
7D
84.0%
1Y
132.3%
Microbix Biosystems
Market Cap: CA$37.0m
A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.
MBX
CA$0.28
7D
16.7%
1Y
-16.4%
Hunan Er-Kang Pharmaceutical
Market Cap: CN¥7.4b
Manufactures and sells APIs, finished drug products, and pharmaceutical excipients in China and internationally.
300267
CN¥3.54
7D
-4.8%
1Y
47.5%
Cleo Diagnostics
Market Cap: AU$50.1m
A biotechnology company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia.
COV
AU$0.37
7D
-11.9%
1Y
-3.9%
Hamlet BioPharma
Market Cap: SEK 746.3m
Engages in the development of drugs for the treatment and prevention of cancer in Sweden.
HAMLET B
SEK 4.20
7D
14.3%
1Y
1.4%